Two Sigma Investments’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.61M Buy
903,611
+508,866
+129% +$1.47M ﹤0.01% 1608
2025
Q1
$849K Buy
394,745
+308,957
+360% +$664K ﹤0.01% 2213
2024
Q4
$332K Sell
85,788
-33,719
-28% -$130K ﹤0.01% 2641
2024
Q3
$783K Sell
119,507
-31,150
-21% -$204K ﹤0.01% 2194
2024
Q2
$1.09M Sell
150,657
-59,815
-28% -$434K ﹤0.01% 1865
2024
Q1
$1.6M Buy
210,472
+176,443
+519% +$1.34M ﹤0.01% 1582
2023
Q4
$155K Sell
34,029
-27,887
-45% -$127K ﹤0.01% 2800
2023
Q3
$245K Sell
61,916
-120,901
-66% -$478K ﹤0.01% 2496
2023
Q2
$572K Sell
182,817
-30,178
-14% -$94.5K ﹤0.01% 2205
2023
Q1
$965K Buy
212,995
+95,581
+81% +$433K ﹤0.01% 1814
2022
Q4
$485K Buy
117,414
+41,472
+55% +$171K ﹤0.01% 1982
2022
Q3
$243K Buy
75,942
+53,230
+234% +$170K ﹤0.01% 1988
2022
Q2
$45K Sell
22,712
-5,700
-20% -$11.3K ﹤0.01% 2288
2022
Q1
$115K Buy
28,412
+9,701
+52% +$39.3K ﹤0.01% 2377
2021
Q4
$202K Sell
18,711
-11,896
-39% -$128K ﹤0.01% 2308
2021
Q3
$353K Buy
+30,607
New +$353K ﹤0.01% 2131
2020
Q3
Sell
-14,149
Closed -$182K 2152
2020
Q2
$182K Sell
14,149
-4,465
-24% -$57.4K ﹤0.01% 1765
2020
Q1
$172K Sell
18,614
-18,324
-50% -$169K ﹤0.01% 1634
2019
Q4
$492K Sell
36,938
-1,759
-5% -$23.4K ﹤0.01% 1710
2019
Q3
$343K Buy
38,697
+10,183
+36% +$90.3K ﹤0.01% 1594
2019
Q2
$407K Buy
28,514
+11,010
+63% +$157K ﹤0.01% 1659
2019
Q1
$576K Buy
17,504
+7,578
+76% +$249K ﹤0.01% 1607
2018
Q4
$590K Buy
9,926
+1,637
+20% +$97.3K ﹤0.01% 1525
2018
Q3
$1.16M Buy
8,289
+4,914
+146% +$689K ﹤0.01% 1310
2018
Q2
$414K Sell
3,375
-1,848
-35% -$227K ﹤0.01% 1691
2018
Q1
$467K Buy
5,223
+136
+3% +$12.2K ﹤0.01% 1593
2017
Q4
$282K Buy
5,087
+2,425
+91% +$134K ﹤0.01% 1952
2017
Q3
$112K Buy
+2,662
New +$112K ﹤0.01% 1827
2015
Q2
Sell
-1,641
Closed -$780K 2299
2015
Q1
$780K Buy
+1,641
New +$780K ﹤0.01% 1506